Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902664-25-004920·ALKEON CAPITAL MANAGEMENT LLC
Schedule 13G ownership disclosure
ORIC Pharmaceuticals Inc
Common Stock, par value $0.0001 per share · CUSIP: 68622P109
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Alkeon Capital Management LLC
Shares: 4,504,096.00 · Class: 4.6%
- Panayotis D. Sparaggis
Shares: 4,504,096.00 · Class: 4.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-004920
- Form type
- SCHEDULE 13G/A
- Filer
- ALKEON CAPITAL MANAGEMENT LLC
- CIK
- CIK 1230239
- Filed
- Nov 13, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership